Comparing Aflibercept Monotherapy With Aflibercept Plus Rescue Photodynamic Therapy in Polypoidal Choroidal Vasculopathy PLANET or Asteroid?

被引：3
|
作者：
Browning, David J. [1 ]
机构：
[1] Charlotte Eye Ear Nose & Throat Associates, 6035 Fairview Rd, Charlotte, NC 28210 USA
来源：
JAMA OPHTHALMOLOGY | 2018年 / 136卷 / 07期
关键词：
VEGF TRAP; MACULAR DEGENERATION; RANIBIZUMAB; CONBERCEPT; EFFICACY; SAFETY;
D O I：
10.1001/jamaophthalmol.2018.1799
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：794 / 795
页数：2
相关论文
共 50 条
  • [31] Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
    Kikushima, Wataru
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Yoneyama, Seigo
    Tanabe, Naohiko
    Matsubara, Mio
    Mabuchi, Fumihiko
    Iijima, Hiroyuki
    SCIENTIFIC REPORTS, 2017, 7
  • [32] Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Weng, Hsin-Yu
    Chen, Fang-Ting
    Wang, Ling-Uei
    Huang, Tzu-Lun
    Ho, Wei-Ting
    Chang, Pei-Yao
    Hsu, Yung-Ray
    Chen, Yun-Ju
    Wang, Jia-Kang
    MEDICINA-LITHUANIA, 2024, 60 (08):
  • [33] Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy
    Cho, Han Joo
    Kim, Kyoung Min
    Kim, Hyoung Seok
    Han, Jung Il
    Kim, Chul Gu
    Lee, Tae Gon
    Kim, Jong Woo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 165 : 1 - 6
  • [34] Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
    Wataru Kikushima
    Yoichi Sakurada
    Atsushi Sugiyama
    Seigo Yoneyama
    Naohiko Tanabe
    Mio Matsubara
    Fumihiko Mabuchi
    Hiroyuki Iijima
    Scientific Reports, 7
  • [35] One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy
    Wataru Matsumiya
    Shigeru Honda
    Keiko Otsuka
    Akiko Miki
    Takayuki Nagai
    Hisanori Imai
    Sentaro Kusuhara
    Makoto Nakamura
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 541 - 548
  • [36] Timing of Complete Absence of Polypoidal Lesions on ICG Angiography Following Aflibercept Monotherapy in Polypoidal Choroidal Vasculopathy
    Chaikitmongkol, Voraporn
    Upaphong, Phit
    Patikulsila, Direk
    Jirarattanasopa, Pichai
    Choovuthayakorn, Janejit
    Watanachai, Nawat
    Kunavisarut, Paradee
    Ratanasukon, Mansing
    Bhurayanontachai, Patama
    Bressler, Neil M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [37] Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
    Fukuda, Yoshiko
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Yoneyama, Seigo
    Matsubara, Mio
    Kikushima, Wataru
    Tanabe, Naohiko
    Parikh, Ravi
    Kashiwagi, Kenji
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 12
  • [38] Long-term Treatment Outcome of Intravitreal Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
    Kim, Ye Ji
    Han, Sang Yun
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2018, 59 (03): : 238 - 245
  • [39] One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy
    Matsumiya, Wataru
    Honda, Shigeru
    Otsuka, Keiko
    Miki, Akiko
    Nagai, Takayuki
    Imai, Hisanori
    Kusuhara, Sentaro
    Nakamura, Makoto
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (03) : 541 - 548
  • [40] Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy
    Asano, Shotaro
    Azuma, Keiko
    Shimizu, Kimiko
    Yamamoto, Risako
    Lee, Jinhee
    Murata, Hiroshi
    Inoue, Tatsuya
    Asaoka, Ryo
    Obata, Ryo
    PLOS ONE, 2018, 13 (05):
12345